Amit Kumar Saha, PhD
Transparency Is the Best Medicine: Device Parts Don’t Justify Orange Book Listing
By Amit Kumar Saha, PhD on Jan 9, 2025
Posted In Patents
The US Court of Appeals for the Federal Circuit affirmed a district court’s delisting of patents from the Orange Book because the patent claims did not “claim the drug that was approved” or the active ingredient of the drug that was approved. Teva Branded Pharmaceutical Products R&D, Inc., et al. v. Amneal Pharmaceuticals of New...
Continue Reading